// App-Quantinova.ai

7069 : Recurrent BRAF mutations in bone marrow progenitors of patients with Erdheim-Chester disease.

Researchers

Presenter

  • Jean-Francois Emile

Principal Investigators

  • Fleur Cohen-Aubart

  • Claude Baillou

  • Damien Roos-Weil

  • Matthias Papo

  • Zofia Helias-Rodzewicz

  • Omar Ibrahim Abdel-Wahab

  • Olivier A Bernard

  • Zahir Amoura

  • Francois M Lemoine

  • Julien Haroche

Medical Centers

  • Versailles University and Hospital Ambroise Pare, APHP, Boulogne, France

  • Department of Internal Medicine and French reference Center for Rare Auto-immune and Systemic Diseases, Institut E3M, Assistance Publique-Hopitaux de Paris (AP-HP), Pitie-Salpetriere Hospital, & Universite Pierre et Marie Curie, UPMC, Paris, France

  • Sorbonne Universites, UPMC , UMR-S INSERM U1135, CNRS ERL 8255, Centre d'Immunologie et Maladies Infectieuses (CIMI-Paris), Paris, France

  • U1170 INSERM, equipe labelisee LNCC, Villejuif, France

  • Hospital Ambroise Pare, APHP, University Versailles-SQY, Boulogne-Billancourt, France

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Erdheim-Chester disease

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Cluster of Differentiation 34

  • Ecdysoneless

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved